CryoHoldco is a stem cell bank holding company that is the market leader in Latin America and one of the top 10 largest cord blood banks in the world. CryoHoldco is more five times larger (5X) than any other stem cell bank in Latin America.
Cryoholdco’s Cord Blood Asset in Latin America
Cryoholdco was created in 2015 with the purpose of forming the premier stem cell banking company in Latin America. By the end of 2018, it will be approaching 200,000 stem cell units in storage.
The first asset that was acquired by CryoHoldco was Cryo-Cell Mexico, the first stem cell bank in Latin America. Since investing in Cryo-Cell Mexico in mid 2015, CryoHoldco has been active in the market.
It acquired a controlling interest in a regional stem cell bank in Mexico (Q4 of 2015). Next, it acquired Stem Medicina Regenerativa, the largest stem cell bank in Colombia, in early 2016.
Today, Cryoholdco controls the following cord blood banking assets:
- Cryo-Cell Mexico
- DentCell (Dental stem cell storage company)
- Cord blood bank 1
- Cord blood bank 2
CryoHoldco, Largest Cord Blood Bank in Latin America
Resulting from its aggressive expansion, CryoHoldco represents the largest stem cell banking operation in Latin America.
The company features two state-of-the art lab and storage facilities in Mexico and Colombia, as well as a growing network of 10,000+ affiliated doctors and 100+ sales offices. CryoHoldco’s state-of–the-art storage facility in Guadalajara, Mexico, has a capacity of 300,000 samples.
According to Cryoholdco leadership, the market must be consolidated, so the “larger companies can increase their investment in technology, state –of- the-art storage facilities, participate in clinical trials, improve operating performance and, most importantly, invest in educational programs with doctors and clients to convey the benefits of storing cord blood and tissue.”
Click here to read the full interview with James Alexis Mendez, CFO of Cryoholdco.